Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: geewiz who wrote (439)	1/18/2000 10:32:00 AM
From: GREG FINLEY	Respond to of 534

You don't ever have to apologize for educating yourself. I will try to find out if BJCT will be at the NFID Conf., or at least if the technology will be represented in one of the presentations. Very interesting article here. I REALLY LIKE the fact that "delivery issues (seem) to be the most compelling factor in gene therapy research". I'm getting antsy for the next news release...subject, impact, price impact, etc. If it's only the earnings (20th to the 25th from what I can find out), I just want to see another p.r. soon! Take care Art...and keep on readin'!!! Always, Greg